Which Star Ratings Are Driving Medicare Advantage Quality Gains
Why It Matters
If CMS refines the star‑rating metrics, incentives will better drive comprehensive quality improvements, protecting Medicare beneficiaries and ensuring billions in bonuses translate into real health gains.
Key Takeaways
- •Star rating gains clustered in medication adherence and few clinical measures.
- •Many measures showed little or no improvement over 2015‑2025.
- •Two‑year lag between performance data and bonus weakens incentive.
- •Overlapping federal quality programs concentrate plan investments on shared metrics.
- •CMS should reassess measure selection to better align incentives with outcomes.
Summary
The podcast discusses a new Health Affairs study examining where Medicare Advantage (MA) star‑rating quality gains have come from between 2015 and 2025. While the star system is intended to steer private plans toward better outcomes, the researchers found that most of the rating improvements are driven by a narrow set of medication‑adherence and a few clinical‑process measures, leaving many other metrics flat or even declining.
The analysis highlights two structural challenges. First, star ratings rely on prior‑year data, creating a two‑year lag before plans see bonus payments, which dilutes the immediacy of the financial incentive. Second, not all measures are equally responsive; plans can more readily boost adherence through pharmacy outreach, whereas metrics tied to provider behavior or external factors are harder to move.
Dr. Andrew Anderson notes that plans strategically allocate resources to the most “responsive” measures, especially those that appear across multiple CMS programs, amplifying the effect of overlapping quality initiatives. He points out that the MA star program now distributes roughly $12 billion in bonus payments annually, yet it remains difficult to attribute overall quality gains to any single program.
The findings suggest CMS should revisit its measure selection criteria, consider shortening the performance‑to‑payment lag, and ensure incentives target outcomes that plans can genuinely influence. Without such adjustments, the star system may continue to reward a limited slice of care while leaving broader quality goals unmet.
Comments
Want to join the conversation?
Loading comments...